Palamon scores 3.6x return on sale of Ober Scharrer to €3.5bn-targeting Nordic Capital Fund IX

Palamon Capital Partners has generated a 3.6x return on the sale of German medical treatment provider Ober Scharrer Group to Nordic Capital.